A prospective randomized double masked controlled clinical trial to determine the efficacy of multiple drop centbucridine as an ocular surface anaesthetic.

In this study, the ocular surface anaesthetic and analgesic efficacies of 0.5% and 1% centbucridine both in saline were compared with 4% lignocaine drops in distilled water in normal healthy volunteers divided into three equal groups. In 99 healthy eyes, keeping one eye as an unanaesthetized control, one drop of any of the above three coded drugs was instilled in the contralateral eye, followed by one more drop of the same drug in the same eye after 3 minutes. The oneset of anaesthesia, achievement and duration of peak activity, total duration of action, the depth of analgesia, and period of burning sensation were all noted in this double-masked randomized controlled trial with the various drug solutions. Total peak duration of anaesthetic as well as analgesic effects in the 99 healthy normal eyes were found to be the highest with centbucridine 1%, followed by 4% lignocaine and 0.5% centbucridine respectively.

[1]  R. Pandey,et al.  Centbucridine, a newer topical anaesthetic compared with lignocaine: a randomized double masked single drop instillation clinical trial. , 2003, Indian journal of physiology and pharmacology.

[2]  R. Pandey,et al.  Injectable centbucridine and lidocaine hydrochloride for intraocular surgery. , 1997, Ophthalmic surgery and lasers.

[3]  R. Srivastava,et al.  Evaluation of the genotoxicity of 4-N-butylamino-1,2,3,4-tetrahydroacridine hydrochloride (centbucridine): a new local anaesthetic. , 1992, Cytobios.

[4]  B. Dhawan,et al.  Clinical evaluation of centbucridine in ophthalmic surgery. , 1985, The Indian journal of medical research.

[5]  R. Satoskar,et al.  A comparative study of centbucridine and lidocaine in dental extraction. , 1983, International journal of clinical pharmacology research.

[6]  G. Patnaik,et al.  Evaluation of local anaesthetic activity of 4-N-butylamino-1,2,3,4-tetrahydroacridine hydrochloride (Centbucridine)--a 4-substituted polymethylenequinoline. , 1982, Indian journal of experimental biology.

[7]  N. Sethi,et al.  Chronic toxicity studies on 4-N-butylamino-1,2,3,4-tetrahydroacridine hydrochloride (Centbucridine)--a new local anaesthetic agent. , 1982, Indian journal of experimental biology.

[8]  B. Dhawan,et al.  Experimental evaluation of potential neurotoxicity of 4-N-butylamino 1,2,3,4-tetrahydroacridine hydrochloride (Centbucridine)--a new local anaesthetic agent. , 1982, Indian journal of experimental biology.

[9]  B. Dhawan,et al.  Clinical pharmacology studies on 4-N-butylamino-1,2,3,4-tetrahydroacridine hydrochloride (Centbucridine)--a new local anaesthetic agent. , 1982, Indian journal of experimental biology.

[10]  D. Rosen Anaesthesia in Ophthalmology , 1962, Canadian Anaesthetists' Society journal.